Overexpression of FOXM1 Is a Potential Prognostic Marker in Male Breast Cancer
|
|
- Dortha Cooper
- 6 years ago
- Views:
Transcription
1 Originl Article Oncol Res Tret 2017;40: DOI: / Received: September 13, 2016 Accepted: Jnury 26, 2017 Published online: Mrch 15, 2017 Overexpression of FOXM1 Is Potentil Prognostic Mrker in Mle Brest Cncer Syrine Abdeljoued Ilhem Bettieb Meher Nsri b Olf Adouni Aid Gouch Olf El Amine Hmmoud Boussen c Khled Rhl d Amor Gmoudi Deprtment of Immunohistocytology, Slh Azïz Cncer Institute, Tunis, Tunisi; b Deprtment of Medicl Oncology, Slh Azïz Cncer Institute, Tunis, Tunisi; c Deprtment of Oncology, Abderrhmen Mmi Hospitl, Arin,Tunisi; d Deprtment of Surgicl Oncology, Slh Azïz Cncer Institute, Tunis, Tunisi Keywords FOXM1 Mle brest cncer Prognosis Outcome Therpeutic trget Summry Bckground: Severl studies hve outlined biologicl differences between femle nd mle brest cncer (MBC) nd concluded tht MBC should be considered s n entirely seprte disese. Whether FOXM1 hs ny indiction for prognosis in MBC ptients remins unknown. We sought to exmine the expression levels of FOXM1 in MBC nd to identify the reltionship between FOXM1 expression nd ptient survivl. Ptients nd Methods: FOXM1 expression ws evluted in totl of 130 MBC specimens. Results: FOXM1 ws overexpressed in 37% of the MBC smples. FOXM1 overexpression ws significntly ssocited with tumor size (p = 0.045), histologicl grde (p = 0.048), lymph node metstsis (p = 0.012), Ki-67 prolifertion index (p = 0.016), nd moleculr subtypes (p < 0.001). Multivrite nlyses indicted tht FOXM1 ws n independent prognostic fctor for overll survivl in MBC ptients (p < 0.001, hzrd rtio = 0.69 ( )). Conclusions: Overexpression of FOXM1 ws ssocited with well-estblished mrkers of poor prognosis; thus FOXM1 my represent potentil novel prognostic mrker for MBC S. Krger GmbH, Freiburg Introduction Mle brest cncer Is n uncommon disese ccounting for less thn 1% of ll cncers in men nd only 1% of ll brest cncers [1, 2]. In 2016, the Americn Cncer Society estimted tht bout 2,600 new cses of mle brest cncer will be dignosed in the United Sttes nd tht bout 440 men will die of the disese [3]. Despite its incresing incidence, mle brest cncer remins n understudied disese, thus prognostic fctors nd tretment decisions for ptients with mle brest cncer re extrpolted from studies crried out on femle brest cncer ptients [4, 5]. Ltely, number of studies conducted on mle brest cncer outlined some notble differences compred to femle brest cncer in prognosis nd survivl [6 9], genomic profiling, driver genes, nd microrna [10 15]. These findings highlight the biologicl differences between mle brest cncer nd its femle counterprt nd suggest tht it should be considered s n entirely seprte disese tht needs further investigtion in order to define n optiml clinicl mngement for these ptients. The Forkhed box protein M1, FOXM1, is member of the Forkhed superfmily of trnscription fctors [16, 17]. FOXM1 plys key role in cell prolifertion nd cell cycle progression by promoting both G1/S trnsition nd G2/M progression [18]. Furthermore, mny studies demonstrted tht FOXM1 contributes to ll hllmrks of cncer [19, 20], which explins the numerous emerging studies indicting FOXM1 s n importnt trget for cncer therpy in the ner future tht offers exciting prospects [21 24]. Overexpression of FOXM1 hs been reported in lrge vriety of humn cncers including femle brest cncer [25 27], nd it correlted with tumor progression nd poor prognosis [28]. However, the prognostic vlue of FOXM1 overexpression in mle brest cncer remins unknown. In this study, we sought to investigte the FOXM1 expression level in mle brest cncer nd to evlute its prognostic impct in mle ptients with brest cncer. Fx Informtion@Krger.com S. Krger GmbH, Freiburg Accessible online t: Dr. Syrine Abdeljoued Deprtment of Immunohistocytology Slh Azïz Cncer Institute Bb Sdoun, 1006, Tunis, Tunisi bdeljoued.syrine@hotmil.fr
2 Ptients nd Methods Ptients nd Tissue Smples We reviewed 130 cses of mle brest cncer dignosed t the Tunisin Slh Azïz Cncer Institute between 2004 nd Only ptients with vilble formlin-fixed prffin-embedded mteril nd complete clinicopthologicl dt were included. Clinicl dt included ge, tumor size, histologicl type, histologicl grde, lymph node sttus, TNM stge, distnt metstsis, nd follow-up informtion. 2 experienced pthologists independently grded ll tumors following the Nottinghm grding system [29]. The study ws pproved by the institutionl ethics committee. Immunohistochemistry Hemtoxylin & eosin-stined slides of ech mle brest cncer ptient were reviewed; then representtive res of invsive crcinom were mrked, nd their corresponding tissue blocks were selected. Immunohistochemicl ssys were performed on 4-μm-thick prffin-embedded tumor tissue sections. Briefly, the formlin-fixed prffin-embedded tissue slides were dewxed in xylene nd rehydrted grdully through 3 lcohol chnges. All sections were incubted in boiling citrte buffer (0.01 M, ph 6.0) for ntigen retrievl, nd endogenous peroxidse ctivity ws blocked in 3% hydrogen peroxide. A Snt Cruz blocking serum kit (ImmunoCruz TM rbbit ABC Stining System: sc-2018, Snt Cruz Biotechnology Inc., Snt Cruz, CA, USA) ws used to decrese bckground stining. The slides were then incubted with primry ntibody (nti-foxm1; 1: 300; H-300, Snt Cruz Biotechnology Inc.) t 4 C overnight. Sections were incubted with Snt Cruz biotinylted secondry ntibody nd vidin-biotinylted horserdish peroxidse complex s detection regent, counterstined with hemtoxylin, dehydrted, nd mounted. A brest cncer smple known to express FOXM1 ws used s positive control, while omission of the primry ntibody ws used s negtive control. In ddition, immunohistochemicl nlysis of estrogen receptor (ER), progesterone receptor (PR), humn epiderml growth fctor receptor 2 (HER2), nd Ki-67 prolifertion index were used s immunohistochemicl surrogte mrkers for brest cncer intrinsic subtype definition ccording to the St. Gllen criteri [30]. Evlution of Immunohistochemicl Rection Intensity All slides were evluted by 2 experienced pthologists who were blinded to the ptients dt. FOXM1 expression ws determined bsed on stining intensity nd percentge of cells showing nucler stining with or without cytoplsmic stining using semiquntittive scoring system. Stining intensity ws ssessed s: 0 (negtive), 1 (wek), 2 (moderte), nd 3 (strong). The percentge of FOXM1-positive cells ws scored s follows: 0 (negtive), 1 (1 25%), 2 (26 50%), 3 (51 75%), nd 4 (76 100%). The finl FOXM1 stining score ws determined by multiplying the intensity score nd the percentge score. Score 6 ws used s cutoff to define low FOXM1 expression group nd high FOXM1 expression group (tble 1) [31]. Sttisticl Anlysis Correltion of the expression of FOXM1 with clinicopthologicl fctors ws tested using χ 2 test. The Kpln-Meier method ws used to estblish survivl curves, nd the log-rnk test ws used to perform survivl nlysis. Fctors with significnt prognostic vlue in the univrite Cox regression model were evluted with the multivrite Cox regression model to explore the independent effects on survivl. A p vlue of < 0.05 ws considered sttisticlly significnt. All nlyses were performed using the SPSS 20.0 softwre pckge (IBM Corp., Armonk, NY, USA). Results Clinicopthologicl Fetures of Mle Brest Cncer Ptients The medin ge t dignosis ws 66 yers (rnge yers). The medin tumor size ws 2 cm (rnge cm). 48.5% hd T4 Fig. 1. Immunohistochemicl (IHC) stining of FOXM1 in mle brest cncer tissue: negtive stining for FOXM1 (IHC 250); b wekly positive nucler stining for FOXM1 (IHC 250), inset (IHC 400); c modertely positive nucler stining for FOXM1 (IHC 250), inset (IHC 400); d Strongly positive nucler stining for FOXM1 (IHC 400). Tble 1. Interprettion of FOXM1 immunohistochemicl stining tumors t dignosis. A centrl review of the histopthology reports reveled tht most mle brest cncers were invsive ductl crcinoms (97%; n = 126), 63.8% (n = 83) of cses were grde 2, nd 59.2% (n = 77) hd positive xillry lymph node sttus. Of the 130 mle brest cncer ptients, 90.8% (n = 118) were ER+, 83% (n = 108) were PR+, 7.7% (n = 10) were HER2+, nd 54.6% (n = 71) hd high Ki67 prolifertion index. Using immunohistochemicl surrogtes, 45.4% (n = 59) of our ptients were clssified s luminl A-like, 44.6% (n = 58) s luminl B-like, 5% (n = 6) s HER2-enriched, nd 5% (n = 7) s triple-negtive. 46% (n = 60) of ptients hd distnt metstsis. FOXM1 Expression in Mle Brest Cncer Tissue To investigte the protein expression of FOXM1 in mle brest cncer, we immunostined 130 tissue sections with n nti- FOXM1 ntibody (fig. 1). A predominntly nucler stining pttern ws observed in the mle brest cncer smples. 93% (n = 121) of the mle brest crcinoms expressed FOXM1, only 7% (n = 9) of cses were FOXM1-negtive. However, overll, only 37% (n = 48) were clssified s belonging to the high FOXM1 expression group. SI PCS High FOXM1 expression group. PCS = Positive cell score; SI = stining intensity. 168 Oncol Res Tret 2017;40: Abdeljoued/Bettieb/Nsri/Adouni/Gouch/ El Amine/Boussen/Rhl/Gmoudi
3 Tble 2. FOXM1 expression nd clinicopthologicl chrcteristics in mle brest cncer Chrcteristics Ptients, n (%) FOXM1 expression, n (%) p high low Totl (37.0) 82 (63.0) Age, yers < (26.1) 12 (25.0) 22 (26.8) (73.9) 36 (75.0) 60 (73.2) Pthologicl type IDC 126 (97.0) 47 (98.0) 79 (96.0) IPC 4 (3.0) 1 (2.0) 3 (4.0) Tumor size, cm < 2 41 (31.5) 9 (18.75) 32 (39.0) 2 89 (68.5) 39 (81.25) 50 (61.0) SBR grde (16.2) 3 (6.0) 18 (22.0) 2 83 (63.8) 35 (73.0) 48 (58.5) 3 26 (20.0) 10 (21.0) 16 (19.5) Axillry lymph node sttus Negtive 53 (40.8) 13 (27.1) 40 (48.8) Positive 77 (59.2) 35 (72.9) 42 (51.2) Stge I II 58 (44.6) 22 (45.8) 36 (43.9) III IV 72 (55.4) 26 (54.2) 46 (56.1) ER sttus Negtive 12 (9.2) 5 (10.4) 7 (8.5) Positive 118 (90.8) 43 (89.6) 75 (91.5) PR sttus Negtive 22 (17.0) 10 (20.8) 12 (14.6) Positive 108 (83.0) 38 (79.2) 70 (85.4) HER2 sttus Negtive 120 (92.0) 42 (87.5) 78 (95.1) Positive 10 (8.0) 6 (12.5) 4 (4.9) Ki-67 index, % < (45.4) 11 (22.9) 48 (58.5) (54.6) 37 (77.1) 34 (41.5) Intrinsic moleculr subtypes < Luminl A-like 59 (45.4) 11 (23.0) 48 (58.5) Luminl B-like 58 (44.6) 30 (62.5) 28 (34.2) HER2-enriched 6 (5.0) 1 (2.0) 5 (6.1) Triple-negtive 7 (5.0) 6 (12.5) 1 (1.2) Distnt metstsis No 70 (54.0) 22 (45.8) 48 (58.5) Yes 60 (46.0) 26 (54.2) 34 (41.5) IDC = Invsive ductl crcinom; IPC = invsive ppillry crcinom; SBR = Scrff-Bloom-Richrdson; ER = estrogen receptor; PR = progesterone receptor. Assocition of FOXM1 Expression with Clinicopthologicl Fetures We nlyzed the correltion between FOXM1 expression nd clinicopthologicl fetures in order to determine the clinicopthologicl significnce of this mrker in mle brest cncer. FOXM1 expression ws significntly relted to lrger tumor size (p = 0.045), higher histologicl grde (p = 0.048), lymph node metstsis (p = 0.012), high Ki-67 prolifertion index (p = 0.016), nd intrinsic moleculr subtypes (p < 0.001). Regrding the intrinsic moleculr subtypes, FOXM1 ws more expressed in luminl B-like nd triplenegtive subtypes. 51.7% of the luminl B-like cses nd 85.7% of the triple-negtive cses belonged to the high FOXM1 expression group, wheres only 19% of the luminl A-like cses were observed in the high FOXM1 expression group. Ptients with FOXM1 expression hd significntly poorer overll survivl (OS) (p < 0.001). No sttisticlly significnt correltion between FOXM1 nd ge, histologicl type, ER sttus, PR sttus, HER2 sttus, stge, nd distnt metstsis ws observed (tble 2). Prognostic Significnce of FOXM1 Expression Due to high rte of dvnced-stge disese t presenttion nd distnt metstsis t the time of dignosis, 50% of the ptients died Prognostic Impct of FOXM1 in Mle Brest Cncer Oncol Res Tret 2017;40:
4 Tble 3. Univrite nd multivrite Cox regression nlyses of different prognostic fctors for overll survivl in mle brest cncer ptients Vribles Univrite nlysis Multivrite nlysis HR p 95% CI HR p 95% CI FOXM1, low vs. high < < Age, 60 vs. > 60 yers < Pthologicl type, IDC vs. IPC Size, < 2 vs. 2 cm Grde, 1 vs Axillry lymph node sttus, negtive vs. positive Stge, I II vs. III IV ER sttus, negtive vs. positive PR sttus, negtive vs. positive HER2 sttus, negtive vs. positive Ki67 index, < 20 vs. 20% Intrinsic moleculr subtypes, LA vs. LB vs. HER nriched vs. TN Distnt metstsis, no vs. yes HR = Hzrd rtio; CI = confidence intervl; IDC = invsive ductl crcinom; IPC = invsive ppillry crcinom; ER =estrogen receptor; PR = progesterone receptor; LA = luminl A-like; LB = luminl B-like; TN = triple-negtive. in less thn 12 months fter being dignosed. The medin followup ws 12.5 months (rnge months); 118 deths were reported. In the overll popultion, the 5-yer OS rte ws 43% (95 confidence intervl (CI) ). The Cox proportionl hzrds regression model ws used to exmine the ssocition between clinicopthologicl fetures nd OS. Univrite nlysis showed tht high FOXM1 expression (p < 0.001) nd ge (p < 0.001) were significntly ssocited with OS (tble 3). Moreover, multivrite nlysis identified only FOXM1 expression s n independent prognostic fctor for OS in mle brest cncer ptients (p < 0.001, hzrd rtio (HR) = 0.69 ( )) (tble 3). Furthermore, Kpln-Meier survivl curves reveled tht high FOXM1 expression ws ssocited with poorer prognosis in mle brest cncer (fig. 2). We lso ssessed the prognostic vlue of FOXM1 expression in terms of disese-free survivl (DFS). Univrite nlysis showed tht ge (p < 0.001) nd lymph node metstsis (p < 0.001) were significntly ssocited with DFS, but not FOXM1 expression (p = 0.238). Multivrite nlysis identified ge s the sole independent prognostic fctor for DFS in mle brest cncer ptients (p < 0.001, HR = 1.32 ( )) (tble 4). Discussion Mle brest cncer is n understudied disese tht for long time ws thought to be identicl to its femle counterprt. Ltely, the mle brest cncer reserch field hs witnessed the emergence of new studies tht hve provided evidence tht mle brest cncer is biologiclly different from femle brest cncer [10 15]. Thus, extrpolting from studies crried out on femle ptients with brest cncer is something to be reconsidered. Given the fct tht there re currently few well-defined prognostic mrkers for mle brest cncer, we ssessed FOXM1 s potentil prognostic mrker. Fig. 2. Kpln-Meier nlysis of overll survivl curves in mle brest cncer ptients ccording to FOXM1 expression. FOXM1 is trnscriptionl ctivtor with Forkhed domin tht plys mjor role in the regultion of cell cycle genes nd is thus bckbone of the highly prolifertive nture of cncer cells [32]. Additionlly, long with its min role of stimulting cell cycle progression nd cell growth, FOXM1 promotes ngiogenesis [33, 34] nd contributes to metstsis by stimulting migrtion nd invsion s well s epithelil-mesenchyml trnsition (EMT) [35 37]. Furthermore, FOXM1 countercts senescence nd increses tumor cell resistnce to poptosis [38 40]. FOXM1 lso plys role in promoting the expnsion of undifferentited cncer cells [41]. In short, 170 Oncol Res Tret 2017;40: Abdeljoued/Bettieb/Nsri/Adouni/Gouch/ El Amine/Boussen/Rhl/Gmoudi
5 Tble 4. Univrite nd multivrite Cox regression nlyses of different prognostic fctors for disese-free survivl in mle brest cncer ptients Vribles Univrite nlysis Multivrite nlysis HR p 95% CI HR p 95% CI FOXM1, low vs. high Age, 60 vs. > 60 yers Pthologicl type, IDC vs. IPC Size, < 2 vs. 2 cm Grde, 1 vs Axillry lymph node sttus, negtive vs. positive Stge, I II vs. III IV ER sttus, negtive vs. positive PR sttus, negtive vs. positive HER2 sttus, negtive vs. positive Ki67 index, < 20 vs. 20% Intrinsic moleculr subtypes, LA vs. LB vs. HER2- enriched vs. TN HR = Hzrd rtio; CI = confidence intervl; IDC = invsive ductl crcinom; IPC = invsive ppillry crcinom; ER =estrogen receptor; PR = progesterone receptor; LA = luminl A-like; LB = luminl B-like; TN = triple-negtive. FOXM1 plys centrl role in the mechnistic concepts involved in the development of cncer. In comprtive microrry nlysis conducted by Pilrsky et l. [25], FOXM1 ws consistently nd independently identified s one of the most commonly upregulted genes in solid tumors. Moreover, overexpression of FOXM1 hs been reported in wide rnge of cncers, nmely brest cncer, lung cncer, ovrin cncer, prostte denocrcinom, testiculr cncer, bldder cncer, nd colorectl cncer [17, 42]. In generl, high FOXM1 expression is recognized s n indictor of poor prognosis [43]. Numerous studies reported tht FOXM1 overexpression correlted with tumor histologicl grde or stge nd incidence of metstsis, nd inversely correlted with OS [26, 28, 44]. All in ll, these results suggest tht FOXM1 overexpression correltes with tumor ggressiveness nd progression. Moreover, in severl trils, downregultion of FOXM1 resulted in the inhibition of cncer cell prolifertion nd tumor growth [23, 45]. Tken together, these findings showcse the significnt nd diverse role plyed by FOXM1 in cncer, nd highlight the potentil of FOXM1 trgeted therpy. Despite the fct tht the pnel of mle brest cncer prognostic fctors is limited nd tht there is emerging evidence of the importnce of FOXM1 s prognostic mrker nd therpeutic trget, the prognostic impct of FOXM1 in mle brest cncer hs not been nlyzed so fr. We therefore ssessed FOXM1 s potentil prognostic mrker in mle brest cncer. In this study, we used immunohistochemistry to evlute FOXM1 expression in mle brest cncer tumors. We found FOXM1 to be expressed in 94% of the tumors nd highly expressed in 37% of cses. Interestingly, these results show tht FOXM1 is more expressed in mle thn in femle brest cncer, since previous studies demonstrted tht 87% of femle brest tumors express FOXM1 nd 20% of these were clssified s high-expression [26, 27]. This confirms the ggressive phenotype of mle brest cncer. Additionlly, we found tht FOXM1 expression ws significntly ssocited with lrger tumor size, higher histologicl grde, lymph node metstsis, nd intrinsic moleculr subtypes, which is in line with the literture on femle brest cncer nd other cncer types [31, 43]. Furthermore, FOXM1 expression highly correlted with high Ki-67 prolifertion index (p < 0.001); therefore, we could show tht FOXM1 is prolifertion-ssocited protein in mle brest cncer. It hs been reported tht FOXM1 expression is tightly correlted with HER2 sttus in femle brest cncer, pointing to potentil interction between FOXM1 nd HER2 [26]; however, in our report, we filed to demonstrte significnt ssocition between FOXM1 expression nd HER2 sttus in mle brest cncer, which could be explined by the lower rte of HER2-positive mle brest tumors compred to femle brest cncer [46]. Finlly, we demonstrted tht FOXM1 is n independent prognostic fctor for OS in mle brest cncer, but not for DFS. All in ll, the vst mjority of mle brest tumors expressed FOXM1, referred to by some s the Achilles heel of cncer. While less thn hlf of the cses overexpressed FOXM1, this rte ws higher thn tht reported for femle brest cncer, supporting the emerging evidence tht cler differences between mle nd femle brest cncer re hidden behind biologicl similrities. High expression of FOXM1 ws strongly ssocited with well-estblished mrkers of poor prognosis nd ws identified s n independent prognostic fctor for OS in mle brest cncer. Our study hs some limittions such s the retrospective study design nd the smple size. However, despite these limittions, our findings demonstrte tht FOXM1 hs relible prognostic significnce in mle brest cncer nd my thus become n importnt trget for mle brest cncer therpy in the future. In recent yers, mny studies hve demonstrted the prognostic vlue of FOXM1 for wide rnge of cncers but not mle brest cncer. In our study, we defined FOXM1 s potentil novel prognostic mrker tht could be included in the limited mrker pnel for mle brest cncer. Prognostic Impct of FOXM1 in Mle Brest Cncer Oncol Res Tret 2017;40:
6 Disclosure Sttement The uthors hve no conflict of interest to declre. References 1 Korde LA, Zujewski JA, Kmin L, Giordno S, Domchek S, Anderson WF, Brtlett JM, Gelmon K, Nhleh Z, Bergh J, Cutuli B, Pruneri G, McCskill-Stevens W, Grlow J, Hortobgyi G, Crdoso F: Multidisciplinry meeting on mle brest cncer: summry nd reserch recommendtions. J Clin Oncol 2010; 28: Weiss JR, Moysich KB, Swede H: Epidemiology of mle brest cncer. Cncer Epidemiol Biomrk Prev 2005; 14: Americn Cncer Society: Cncer Fcts nd Figures Atlnt, GA, Americn Cncer Society, Howlder N, Noone AM, Krpcho M, Grshell J, Miller D, Altekruse SF, Kosry CL, Yu M, Ruhl J, Ttlovich Z, Mriotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds): SEER Cncer Sttistics Review, Bethesd, MD, Ntionl Cncer Institute, Johnsen Tber KA, Morisy LR, Osbhr AJ 3rd, Dickinson BD: Mle brest cncer: risk fctors, dignosis, nd mngement (review). Oncol Rep 2010; 24: Giordno SH: A review of the dignosis nd mngement of mle brest cncer. Oncologist 2005; 10: Nilsson C, Kolidi A, Johnsson I, Ahlin C, Thorstenson S, Bergkvist L, Hedenflk I, Fjällskog ML: High prolifertion is ssocited with inferior outcome in mle brest cncer ptients. Mod Pthol 2013; 26: Lcle MM, vn der Pol C, Witkmp A, vn der Wll E, vn Diest PJ: Prognostic vlue of mitotic index nd Bcl2 expression in mle brest cncer. PLoS One 2013; 8:e Nilsson C, Holmqvist M, Bergkvist L, Hedenflk I, Lmbe M, Fjällskog ML: Similrities nd differences in the chrcteristics nd primry tretment of brest cncer in men nd women popultion bsed study (Sweden). Act Oncol 2011; 50: Piscuoglio S, Ng CK, Murry MP, Guerini-Rocco E, Mrtelotto LG, Geyer FC, Bidrd FC, Bermn S, Fusco N, Skr RA, Eberle CA, De Mttos-Arrud L, Mcedo GS, Akrm M, Bsln T, Hicks JB, King TA, Brogi E, Norton L, Weigelt B, Hudis CA, Reis-Filho JS: The genomic lndscpe of mle brest cncers. Clin Cncer Res 2016; 22: Johnsson I, Nilsson C, Berglund P, Luss M, Ringnér M, Olsson H, Luts L, Sim E, Thorstensson S, Fjällskog ML, Hedenflk I: Gene expression profiling of primry mle brest cncers revels two unique subgroups nd identifies N-cetyltrnsferse-1 (NAT1) s novel prognostic biomrker. Brest Cncer Res 2012; 14:R Johnsson I, Nilsson C, Berglund P, Strnd C, Jönsson G, Stf J, Ringnér M, Nevnlinn H, Brkrdottir RB, Borg A, Olsson H, Luts L, Fjällskog ML, Hedenflk I: High-resolution genomic profiling of mle brest cncer revels differences hidden behind the similrities with femle brest cncer. Brest Cncer Res Tret 2011; 129: Johnsson I, Ringnér M, Hedenflk I: The lndscpe of cndidte driver genes differs between mle nd femle brest cncer. PLoS One 2013; 10:e Lehmnn U, Streichert T, Otto B, Albt C, Hsemeier B, Christgen H, Schipper E, Hille U, Kreipe HH, Länger F: Identifiction of differentilly expressed micrornas in humn mle brest cncer. BMC Cncer 2010; 10: Fssn M, Bff R, Plzzo JP, Lloyd J, Crosriol M, Liu CG, Volini S, Alder H, Rugge M, Croce CM, Rosenberg A: MicroRNA expression profiling of mle brest cncer. Brest Cncer Res 2009; 11:R Teh MT, Wong ST, Neill GW, Ghli LR, Philpott MP, Quinn AG: FOXM1 is downstrem trget of Gli1 in bsl cell crcinoms. Cncer Res 2002; 62: Wierstr I, Alves J: FOXM1, typicl prolifertionssocited trnscription fctor. Biol Chem 2007; 388: Loukili J, Kooistr MR, Brás A, Kuw J, Kerkhoven RM, Morrison A, Clevers H, Medem RH: FoxM1 is required for execution of the mitotic progrmme nd chromosome stbility. Nt Cell Biol 2005; 7: Hnhn D, Weinberg RA: Hllmrks of cncer: the next genertion. Cell 2011; 144: Koo CY, Muir KW, Lm EW: FOXM1: from cncer initition to progression nd tretment. Biochim Biophys Act 2012; 1819: Xu XS, Mio RC, Wn Y, Zhng LQ, Qu K, Liu C: FoxM1 s novel therpeutic trget for cncer drug therpy. Asin Pc J Cncer Prev 2015; 16: Wng M, Grtel AL: The suppression of FOXM1 nd its trgets in brest cncer xenogrft tumors by sirna. Oncotrget 2011; 2: Briest F, Berg E, Grss I, Freitg H, Kemmerer D, Lewens F, Christen F, Arsenic R, Altendorf-Hofmnn A, Kunze A, Sänger J, Knösel T, Siegmund B, Hummel M, Grbowski P: FOXM1: novel drug trget in gstroenteropncretic neuroendocrine tumors. Oncotrget 2015; 10: Gormlly MV, Dexheimer TS, Mrsico G, Snders DA, Lowe C, Mtk-Vinković D, Michel S, Jdhv A, Ri G, Mloney DJ, Simeonov A, Blsubrmnin S: Suppression of the FOXM1 trnscriptionl progrmme vi novel smll molecule inhibition. Nt Commun 2014; 5: Pilrsky C, Wenzig M, Specht T, Seger HD, Grutzmnn R: Identifiction nd vlidtion of commonly overexpressed genes in solid tumors by comprison of microrry dt. Neoplsi 2004; 6: Bekts N, Hf At, Veeck J, Wild PJ, Lüscher-Firzlff J, Hrtmnn A, Knüchel R, Dhl E: Tight correltion between expression of the Forkhed trnscription fctor FOXM1 nd HER2 in humn brest cncer. BMC Cncer 2008; 8: Bergmschi A, Mdk-Erdogn Z, Kim YJ, Choi YL, Lu H, Ktzenellenbogen BS: The forkhed trnscription fctor FOXM1 promotes endocrine resistnce nd invsiveness in estrogen receptor-positive brest cncer by expnsion of stem like cncer cells. Brest Cncer Res 2014; 5: Chu XY, Zhu ZM, Chen LB, Wng JH, Su QS, Yng JR, Lin Y, Xue LJ, Liu XB, Mo XB: FOXM1 expression correltes with tumor invsion nd poor prognosis of colorectl cncer. Act Histochem 2012; 114: Elston CW, Ellis IO: Pthologicl prognostic fctors in brest cncer. I. The vlue of histologicl grde in brest cncer: experience from lrge study with longterm follow-up. Histopthology 1991; 19: Goldhirsch A, Winer EP, Cotes AS, Gelber RD, Piccrt-Gebhrt M, Thürlimnn B, Senn HJ; Pnel members: Personlizing the tretment of women with erly brest cncer: highlights of the St Gllen Interntionl Expert Consensus on the Primry Therpy of Erly Brest Cncer Ann Oncol 2013; 24: Ahn H, Sim J, Abdul R, Chung MS, Pik SS, Oh YH, Prk CK, Jng K: Incresed expression of forkhed box M1 is ssocited with ggressive phenotype nd poor prognosis in estrogen receptor-positive brest cncer. Koren Med Sci 2015; 30: Cost RH: FoxM1 dnces with mitosis. Nt Cell Biol 2005; 7: Li Q, Zhng N, Ji Z, Le X, Di B, Wei D, Hung S, Tn D, Xie K: Criticl role nd regultion of trnscription fctor FoxM1 in humn gstric cncer ngiogenesis nd progression. Cncer Res 2009; 69: Zhng Y, Zhng N, Di B, Liu M, Swy R, Xie K, Hung S: FoxM1B trnscriptionlly regultes vsculr endothelil growth fctor expression nd promotes ngiogenesis nd growth of gliom cells. Cncer Res 2008; 68: Prk HJ, Gusrov G, Wng Z, Crr JR, Li J, Kim KH, Qiu J, Prk YD, Willimson PR, Hy N, Tyner AL, Lu LF, Cost RH, Rychudhuri P: Deregultion of FoxM1b leds to tumour metstsis. EMBO Mol Med 2011; 3: Ahmd A, Wng Z, Kong D, Ali S, Li Y, Bnerjee S, Ali R, Srkr FH: FoxM1 downregultion leds to inhibition of prolifertion, migrtion nd invsion of brest cncer cells through the modultion of extr-cellulr mtrix degrding fctors. Brest Cncer Res Tret 2010; 122: Blli D, Ustiyn V, Zhng Y, Wng IC, Msino AJ, Ren X, Whitsett JA, Klinichenko VV, Klin TV: Foxm1 trnscription fctor is required for lung fibrosis nd epithelil-to mesenchyml trnsition. EMBO J 2013; 32: Zeng J, Wng L, Li Q, Li W, Björkholm M, Ji J, Xu D: FoxM1 is up-regulted in gstric cncer nd its inhibition leds to cellulr senescence, prtilly dependent on p27 kip1. J Pthol 2009; 218: Qu K, Xu X, Liu C, Wu Q, Wei J, Meng F, Zhou L, Wng Z, Lei L, Liu: Negtive regultion of trnscription fctor FoxM1 by p53 enhnces oxlipltin-induced senescence in heptocellulr crcinom. Cncer Lett 2013; 331: Pndit B, Grtel AL: FoxM1 knockdown sensitizes humn cncer cells to protesome inhibitor induced poptosis but not to utophgy. Cell Cycle 2011; 10: Crr JR, Kiefer MM, Prk HJ, Li J, Wng Z, Fontnros J, DeWl D, Kopnj D, Benevolensky EV, Guzmn G, Rychudhuri P: FoxM1 regultes mmmry luminl cell fte. Cell Rep 2012; 1: Mytt SS, Lm EW: The emerging roles of forkhed box (Fox) proteins in cncer. Nt Rev Cncer 2007; 7: Di J, Yng L, Wng J, Xio Y, Run Q: Prognostic vlue of FOXM1 in ptients with mlignnt solid tumor: met-nlysis nd system review. Dis Mrkers 2015; 2015: Xi JT, Wng H, Ling LJ, Peng BG, Wu ZF, Chen LZ, Xue L, Li Z, Li W: Overexpression of FOXM1 is ssocited with poor prognosis nd clinicopthologic stge of pncretic ductl denocrcinom. Pncres 2012; 41: Yng C, Chen H, Yu L, Shn L, Xie L, Hu J, Chen T, Tn Y: Inhibition of FOXM1 trnscription fctor suppresses cell prolifertion nd tumor growth of brest cncer. Cncer Gene Ther 2013; 20: Ottini L, Cplbo C, Rizzolo P, Silvestri V, Bronte G, Rizzo S, Russo A: HER2-positive mle brest cncer: n updte. Brest Cncer (Dove Med Press) 2010; 2: Oncol Res Tret 2017;40: Abdeljoued/Bettieb/Nsri/Adouni/Gouch/ El Amine/Boussen/Rhl/Gmoudi
Original Article Prognostic and clinicopathologic significance of AEG-1/MTDH and E-cadherin expression in human gallbladder carcinoma
Int J Clin Exp Pthol 2018;11(12):6025-6031 www.ijcep.com /ISSN:1936-2625/IJCEP0086349 Originl Article Prognostic nd clinicopthologic significnce of AEG-1/MTDH nd E-cdherin expression in humn gllbldder
More informationEsophageal carcinoma is the eighth most common cancer
ORIGINAL ARTICLE Tumor-Strom Rtio Is n Independent Predictor for Survivl in Esophgel Squmous Cell Crcinom Ki Wng, MD,* Wei M, MD,* Jinbo Wng, MD,* Ling Yu, MD, Xiomei Zhng, MD, Zhenbo Wng, MD, Bingxu Tn,
More informationImpact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors
Originl Article Impct of Positive Nodl Metstses in Ptients with Thymic Crcinom nd Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, nd Jennifer L. Sullivn, MD Introduction: Thymic crcinoms
More informationPrognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with nonmetastatic
Crcinogenesis, 2015, Vol. 36, No. 2, 243 248 doi:10.1093/crcin/bgu247 Advnce Access publiction December 18, 2014 Originl Mnuscript originl mnuscript Prognostic significnce of pretretment serum levels of
More informationCheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer
CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn
More informationSignificance of Expression of TGF- in Pulmonary Metastasis in Non-small Cell Lung Cancer Tissues
Originl Article Significnce of Expression of in Pulmonry Metstsis in Non-smll Cell Lung Cncer Tissues Hisshi Sji, Hruhiko Nkmur, Idiris Awut, Norihito Kwski, Msru Hgiwr, Akihiko Ogt, Mkoto Hosk, Tkmoto
More informationORIGINAL ARTICLE ABSTRACT INTRODUCTION
ORIGINAL ARTICLE LOSS OF EPCAM STAINING CORRELATES WITH POOR OUTCOME IN CRC, Wng et l. Reduction in membrnous immunohistochemicl stining for the intrcellulr domin of epithelil cell dhesion molecule correltes
More informationONCOLOGY LETTERS 14: , China Medical University, Shenyang, Liaoning , P.R. China
4890 Expression of vsculr endothelil growth fctor nd cspse 3 in mucinous brest crcinom nd infiltrting ductl crcinom not otherwise specified, nd the correltion with disese free survivl QIULI WANG 1, LISHA
More informationEfficacy of Pembrolizumab in Patients With Advanced Melanoma With Stable Brain Metastases at Baseline: A Pooled Retrospective Analysis
Efficcy of Pembrolizumb in Ptients With Advnced Melnom With Stble Brin Metstses t Bseline: A Pooled Retrospective Anlysis Abstrct 1248PD Hmid O, Ribs A, Dud A, Butler MO, Crlino MS, Hwu WJ, Long GV, Ancell
More informationLung cancer is the leading cause of cancer death worldwide, EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas
Originl Article EGFR Muttion nd Brin Metstsis in Pulmonry Adenocrcinoms Dong-Yeop Shin, MD,* Im Il N, MD,* Cheol Hyeon Kim, MD, PhD, Sunhoo Prk, MD, PhD, HeeJong Bek, MD, PhD, nd Sung Hyun Yng, MD, PhD*
More informationCHEST. Thyroid transcription factor 1 (TTF-1) is an important. Original Research
CHEST Originl Reserch Clinicl Significnce of Thyroid Trnscription Fctor-1 in Advnced Lung Adenocrcinom Under Epiderml Growth Fctor Receptor Tyrosine Kinse Inhibitor Tretment Kuei-Pin Chung, MD; Yen-Tsung
More informationClassic Papillary Thyroid Carcinoma with Tall Cell Features and Tall Cell Variant Have Similar Clinicopathologic Features
The Koren Journl of Pthology 2014; 48: 201-208 ORIGINAL ARTICLE Clssic Ppillry Thyroid Crcinom with Tll Cell Fetures nd Tll Cell Vrint Hve Similr Clinicopthologic Fetures Woo Jin Oh 1 Young Sub Lee 1 Uiju
More informationUsing proliferative markers and Oncotype DX in therapeutic decision-making for breast cancer: the B.C. experience
ORIGINAL ARTICLE Using prolifertive mrkers nd Oncotype DX in therpeutic decision-mking for brest cncer: the B.C. experience E. Bxter bsc,* L. Gondr btech pdc, C. Lohrisch md, S. Chi md, K. Gelmon md, M.
More informationStudy on the association between PI3K/AKT/mTOR signaling pathway gene polymorphism and susceptibility to gastric
JBUON 2017; 22(6): 1488-1493 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mil: editoril_office@jbuon.com ORIGINAL ARTICLE Study on the ssocition between PI3K/AKT/mTOR signling pthwy gene polymorphism
More informationClinical manifestations in patients with alpha-fetoprotein producing gastric cancer
Curr Oncol, Vol. 21, pp. e394-399; doi: http://dx.doi.org/10.3747/co.21.1768 CLINICAL MANIFESTATIONS IN AFP PRODUCING GASTRIC CANCER ORIGINAL ARTICLE Clinicl mnifesttions in ptients with lph-fetoprotein
More informationAmerican Joint Committee on Cancer Staging and Clinicopathological High-Risk Predictors of Ocular Surface Squamous Neoplasia
Americn Joint Committee on Cncer Stging nd Clinicopthologicl High-Risk Predictors of Oculr Surfce Squmous Neoplsi A Study From Tertiry Eye Center in Indi Sheetl Chuhn, MSc; Seem Sen, MD; Anjn Shrm, PhD;
More informationNeutrophil lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors
2454 Neutrophil lymphocyte rtio predicts survivl in pncretic neuroendocrine tumors GUOPEI LUO 1 3*, CHEN LIU 1 3*, HE CHENG 1 3*, KAIZHOU JIN 1 3, MENG GUO 1 3, YU LU 1 3, JIANG LONG 1 3, JIN XU 1 3, QUANXING
More informationRelation of Tumor Size, Lymph Node Status, and Survival in
Reltion of Tumor Size, Lymph Node Sttus, nd Survivl in 24,74 Brest Cncer Cses CHRISTINE L. CARTER, PHD, MPH,* CAROL ALLEN, PHD,t AND DONALD E. HENSON, MD* Two of the most importnt prognostic indictors
More informationOne of the most important biological mechanisms of
Brief Report Serum Thymidine Kinse 1 Activity in the Prognosis nd Monitoring of Chemotherpy in Lung Cncer Ptients: A Brief Report Benjmin Nismn, PhD,* Hovv Nechushtn, MD, PhD,* Him Birn, MD, Hds Gntz-Sorotsky,
More informationSUPPLEMENTARY INFORMATION
doi:0.08/nture0987 SUPPLEMENTARY FIGURE Structure of rbbit Xist gene. Exons re shown in boxes with romn numbers, introns in thin lines. Arrows indicte the locliztion of primers used for mplifiction. WWW.NATURE.COM/NATURE
More informationSupplementary Online Content
Supplementry Online Content Zulmn DM, Pl Chee C, Ezeji-Okoye SC, et l. Effect of n intensive outptient progrm to ugment primry cre for high-need Veterns Affirs ptients: rndomized clinicl tril. JAMA Intern
More informationRESEARCH ARTICLE. Wen Li 1, Jing Deng 2 *, Shuang-Shuang Wang 1, Liang Ma 1, Jiang Pei 1, Xiao-Xi Zeng 1, Jian-Xin Tang 1. Abstract.
DOI:http://dx.doi.org/10.7314/APJCP.2014.15.24.10937 Methyltion of the RAR-β Gene nd Cigrette Smoking in NSCLC in Southern-Centrl Chinese RESEARCH ARTICLE Assocition of Methyltion of the RAR-β Gene with
More informationMICRO RNA-21 EXPRESSION LEVELS IN INVASIVE BREAST CARCINOMA WITH A NON-INVASIVE COMPONENT
Arch. Biol. Sci., Belgrde, 67(4), 1285-1295, 2015 DOI:10.2298/ABS150327105P MICRO RNA-21 EXPRESSION LEVELS IN INVASIVE BREAST CARCINOMA WITH A NON-INVASIVE COMPONENT Nin Petrović 1,*, Snežn Jovnović-Ćupić
More informationHigh EGFR mrna expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy
INTERNATIONAL JOURNAL OF ONCOLOGY 38: 629-641, 2011 High EGFR mrna expression is prognostic fctor for reduced survivl in pncretic cncer fter gemcitbine-bsed djuvnt chemotherpy Hyto Fujit 1, Kenoki Ohuchid
More informationAsian Journal of Andrology (2017) 19,
(2017) 19, 20 25 2017 AJA, SIMM & SJTU. All rights reserved 1008-682X www.sindro.com; www.jndrology.com Prostte Cncer Open Access ORIGINAL ARTICLE Refining the Americn Urologicl Assocition nd Americn Society
More informationAssociation between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B cell lymphoma
264 Assocition between LAPTM4B gene polymorphism nd susceptibility to nd prognosis of diffuse lrge B cell lymphom HUIRONG DING 1*, XIAOJING CHENG 2*, NING DING 3*, ZHIHUA TIAN 1, JUN ZHU 3, CHUNLIAN ZHOU
More informationPrognostic factors in tongue cancer relative importance of demographic, clinical and histopathological factors
British Journl of Cncer (2000) 83(5), 614 619 doi: 10.1054/ bjoc.2000.1323, vilble online t http://www.idelibrry.com on Prognostic fctors in tongue cncer reltive importnce of demogrphic, clinicl nd histopthologicl
More informationAssociation of PTEN expression with liver function and inflammatory changes in patients with liver cancer after chemotherapy
ONCOLOGY LETTERS Assocition of PTEN expression with liver function nd inflmmtory chnges in ptients with liver cncer fter chemotherpy JIXIANG ZHOU nd XIAOLI LI Deprtment of Heptobiliry Surgery, Xingy Hospitl,
More informationAge related differences in prognosis and prognostic factors among patients with epithelial ovarian cancer
MOLECULAR AND CLINICAL ONCOLOGY 9: 329-334, 2018 Age relted differences in prognosis nd prognostic fctors mong ptients with epithelil ovrin cncer KENJI YOSHIKAWA, TAKESHI FUKUDA, RYO UEMURA, HIROAKI MATSUBARA,
More informationClinical significance of zinc finger E box binding homeobox 1 mrna levels in peritoneal washing for gastric cancer
MOLECULAR AND CLINICAL ONCOLOGY 3: 435-441, 2015 Clinicl significnce of zinc finger E box binding homeobox 1 mrna levels in peritonel wshing for gstric cncer NORIMITSU YABUSAKI, SUGURU YAMADA, TOSHIFUMI
More informationSYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT
Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of
More informationBody mass index, waist-to-hip ratio, and metabolic syndrome as predictors of middle-aged men's health
Originl Article - Sexul Dysfunction/Infertility pissn 2005-6737 eissn 2005-6745 Body mss index, wist-to-hip rtio, nd metbolic syndrome s predictors of middle-ged men's helth Jung Hyun Prk *, In-Chng Cho
More informationJournal of Hainan Medical University.
132 Journl of Hinn Medicl University 2017; 23(11): 132-136 Journl of Hinn Medicl University http://www.hnykdxxb.com Assessment of the efficcy nd sfety of bronchil rtery perfusion chemotherpy combined with
More informationBreast carcinoma grading by histologic features has
Originl Articles Mitotic Index of Invsive Brest Crcinom Achieving Cliniclly Meningful Precision nd Evluting Tertil Cutoffs John S. Meyer, MD; Eric Costto, PhD; Hns Peter Grf, PhD Context. Mitotic figure
More informationPossible predictive role of cancer/testis antigens in breast ductal carcinoma in situ
ONCOLOGY LETTS Possible predictive role of cncer/testis ntigens in brest ductl crcinom in situ ANA ROGULJIC 1, GULIO SPAGNOLI 2, ANTONIO JURETIC 3, BOZENA SARCEVIC 4, MARIJA BANOVIC 5 nd LIDIJA BEKETIC
More informationCommunity. Profile Lewis & Clark County. Public Health and Safety Division
Community Helth Profile 2015 Lewis & Clrk County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationEfficacy of Sonidegib in Patients With Metastatic BCC (mbcc)
AAD 216 eposter 3368 Efficcy of Sonidegib in Ptients With Metsttic BCC (mbcc) Colin Morton, 1 Michel Migden, 2 Tingting Yi, 3 Mnish Mone, 3 Dlil Sellmi, 3 Reinhrd Dummer 4 1 Stirling Community Hospitl,
More informationExpression of Three Cell Cycle Inhibitors during Development of Adipose Tissue
Expression of Three Cell Cycle Inhiitors during Development of Adipose Tissue Jiin Zhng Deprtment of Animl Sciences Advisor: Michel E. Dvis Co-dvisor: Kichoon Lee Development of niml dipose tissue Hypertrophy
More informationCommunity. Profile Yellowstone County. Public Health and Safety Division
Community Helth Profile 2015 Yellowstone County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationEffects of modified FOLFOX-6 chemotherapy on cellular immune function in patients with gastric cancer
ONCOLOGY LETTERS 15: 8635-8640, 2018 Effects of modified FOLFOX-6 chemotherpy on cellulr immune function in ptients with gstric cncer LIANG WANG 1, DONGER ZHOU 1, HAITAO REN 2 nd YAN CHEN 3 Deprtments
More informationCommunity. Profile Powell County. Public Health and Safety Division
Community Helth Profile 2015 Powell County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationCommunity. Profile Missoula County. Public Health and Safety Division
Community Helth Profile 2015 Missoul County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationCommunity. Profile Big Horn County. Public Health and Safety Division
Community Helth Profile 2015 Big Horn County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationPatient Survival After Surgical Treatment of Rectal Cancer
Originl Article Ptient Survivl After Surgicl Tretment of Rectl Cncer Impct of Surgeon nd Hospitl Chrcteristics Dvid A. Etzioni, MD, MSHS 1,2 ; Toni M. Young-Fdok, MD, MS 1 ; Robert R. Cim, MD, MA 2,3 ;
More informationAssociation on polymorphisms in LncRNA HOTAIR and susceptibility to HNSCC in Chinese population
Europen Review for Medicl nd Phrmcologicl Sciences 2018; 22: 702-706 Assocition on polymorphisms in LncRNA HOTAIR nd susceptibility to HNSCC in Chinese popultion B. WU 1, J. LIU 2, B. WANG 2, X. LIAO 1,
More informationDA XU *, XIAOFENG LIU *, LIJUN WANG and BAOCAI XING
ONCOLOGY LETTERS Heptectomy plus djuvnt trnsctheter rteril chemoemboliztion improves the survivl rte of ptients with multicentric occurrence of heptocellulr crcinom DA XU *, XIAOFENG LIU *, LIJUN WANG
More informationPhosphorylated p70s6k in noninvasive low grade urothelial carcinoma of the bladder: correlation with tumor recurrence
(2014) 16, 611 617 2014 AJA, SIMM & SJTU. All rights reserved 1008-682X www.sindro.com; www.jndrology.com Mle Helth Open Access ORIGINAL ARTICLE Phosphorylted p70s6k in noninvsive low grde urothelil crcinom
More informationAndrogen Receptor Expression Shows Distinctive Significance in ER Positive and Negative Breast Cancers
Ann Surg Oncol (2014) 21:2218 2228 DOI 10.1245/s10434-014-3629-2 ORIGINAL ARTICLE BREAST ONCOLOGY Androgen Receptor Expression Shows Distinctive Significnce in ER Positive nd Negtive Brest Cncers Juli
More informationA retrospective, single center cohort study on 65 patients with primary retroperitoneal liposarcoma
ONCOLOGY LETTERS 15: 1799-1810, 2018 A retrospective, single center cohort study on 65 ptients with primry retroperitonel liposrcom YI XI WU 1, JUN YAN LIU 1*, JIA JIA LIU 1*, PENG YAN 1, BO TANG 1, YOU
More informationAberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8 + T lymphocytes in human cholangiocarcinoma
ONCOLOGY REPORTS 36: 419-427, 2016 Aberrnt expression of B7-H4 correltes with poor prognosis nd suppresses tumor-infiltrtion of CD8 + T lymphocytes in humn cholngiocrcinom Xin Zho *, Fei Guo *, Zhonghu
More informationOpioid Use and Survival at the End of Life: A Survey of a Hospice Population
532 Journl of Pin nd Symptom Mngement Vol. 32 No. 6 December 2006 NHPCO Originl Article Opioid Use nd Survivl t the End of Life: A Survey of Hospice Popultion Russell K. Portenoy, MD, Un Sibircev, BA,
More informationPrognostic implications of the intrinsic molecular subtypes in male breast cancer
JBUON 2017; 22(2): 377-382 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Prognostic implications of the intrinsic molecular subtypes in male
More informationCommunity. Profile Anaconda- Deer Lodge County. Public Health and Safety Division
Community Helth Profile 2015 Ancond- Deer Lodge County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12
More informationPNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :
PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged
More informationMOLECULAR AND CLINICAL ONCOLOGY 7: , 2017
MOLECULAR AND CLINICAL ONCOLOGY 7: 787-797, 2017 Evlution of epiderml growth fctor receptor serum levels nd their ssocition with clinicopthologicl chrcteristics in ptients with colorectl cncer MEHMET KARABULUT
More informationClinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number
EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess
More informationMethylation of a Panel of MicroRNA Genes Is a Novel Biomarker for Detection of Bladder Cancer
EUROPEAN UROLOGY 6 (1) 191 11 vilble t www.sciencedirect.com journl homepge: www.europenurology.com Urothelil Cncer Methyltion of Pnel of MicroRNA Genes Is Novel Biomrker for Detection of Bldder Cncer
More informationBarrier to autointegration factor 1: A novel biomarker for gastric cancer
ONCOLOGY LETTERS Brrier to utointegrtion fctor 1: A novel biomrker for gstric cncer JUNJUN LI 1, BINGBING HU 2, LEI FANG 3, YANG GAO 1, SHUAI SHI 3, HAOYU HE 1, XIAOMEI LIU 1 nd CAIJUN YUAN 1 1 Deprtment
More informationA review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital
MEDICAL ONCOLOGY A review of the ptterns of docetxel use for hormone-resistnt prostte cncer t the Princess Mrgret Hospitl S.N. Chin MD,* L. Wng MSc, M. Moore MD,* nd S.S. Sridhr MD MSc* ABSTRACT Bckground
More informationMetformin and breast cancer stage at diagnosis: a population-based study
ORIGINAL ARTICLE METFORMIN AND BREAST CANCER STAGE AT DIAGNOSIS, Leg et l. Metformin nd brest cncer stge t dignosis: popultion-bsed study I.C. Leg md msc,* K. Fung msc,* P.C. Austin phd, nd L.L. Lipscombe
More informationMOLECULAR AND CLINICAL ONCOLOGY 5: , 2016
MOLECULAR AND CLINICAL ONCOLOGY 5: 429-436, 2016 Improvement of survivl with postmstectomy rdiotherpy in ptients with 1-3 positive xillry lymph nodes: A systemtic review nd met-nlysis of the current literture
More informationCopy Number ID2 MYCN ID2 MYCN. Copy Number MYCN DDX1 ID2 KIDINS220 MBOAT2 ID2
Copy Numer Copy Numer Copy Numer Copy Numer DIPG38 DIPG49 ID2 MYCN ID2 MYCN c DIPG01 d DIPG29 ID2 MYCN ID2 MYCN e STNG2 f MYCN DIPG01 Chr. 2 DIPG29 Chr. 1 MYCN DDX1 Chr. 2 ID2 KIDINS220 MBOAT2 ID2 Supplementry
More informationCME/SAM. Study on Hyperuricemia in HBV-Associated Glomerulonephritis
AJCP / Originl Article Study on Hyperuricemi in HBV-Associted Glomerulonephritis Yongze Zhung, MD, PhD, 1 Yingho Yu, MD, PhD, 2 Yingfng Hung, MD, 3 nd Xiorong Zhong, MD 1 From the 1 Deprtment of Nephrology,
More informationInvasive Pneumococcal Disease Quarterly Report. July September 2017
Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report
More informationPD L1 expression is associated with advanced non small cell lung cancer
ONCOLOGY LETTERS 12: 921-927, 2016 PD L1 expression is ssocited with dvnced non smll cell lung cncer ZHIQUAN CHEN 1 3, JIANDONG MEI 3 5, LUNXU LIU 4,5, GUOCHEN WANG 2, ZUOSHENG LI 2, JINGPU HOU 2, QIUYANG
More informationInhaled Corticosteroid Is Associated With an Increased Risk of TB in Patients With COPD
CHEST Originl Reserch Inhled Corticosteroid Is Associted With n Incresed Risk of TB in Ptients With COPD Jung-Hyun Kim, MD ; Ji-Soo Prk, MD ; Kyung-Ho Kim, MD ; Hye-Cheol Jeong, MD ; Eun-Kyung Kim, MD
More informationGenetic polymorphisms in the TERT-CLPTM1L region and lung cancer susceptibility in Chinese males
1588 Genetic polymorphisms in the TERT-CLPTM1L region nd lung cncer susceptibility in Chinese mles XUYANG XIAO 1 nd WUBIN HE 2 1 Deprtment of Thorcic Surgery nd 2 Biologicl Therpy Center Lbortory, The
More informationA cross-sectional and follow-up study of leukopenia in tuberculosis patients: prevalence, risk factors and impact of anti-tuberculosis
Originl Article A cross-sectionl nd follow-up study of leukopeni in tuberculosis ptients: prevlence, risk fctors nd impct of nti-tuberculosis tretment Fei-Shen Lin 1 *, Mei-Ying Wu 2 *, Wen-Jun Tu 3, Hong-Qiu
More informationAssessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II
Assessment of Depression in Multiple Sclerosis Vlidity of Including Somtic Items on the Beck Depression Inventory II Peggy Crwford, PhD; Noh J. Webster, MA Signs nd symptoms of multiple sclerosis (MS)
More informationGeographical influence on digit ratio (2D:4D): a case study of Andoni and Ikwerre ethnic groups in Niger delta, Nigeria.
Journl of Applied Biosciences 27: 1736-1741 ISSN 1997 5902 Geogrphicl influence on digit rtio (2D:4D): cse study of Andoni nd Ikwerre ethnic groups in Niger delt, Nigeri. Gwunirem, Isrel U 1 nd Ihemelndu,
More informationOriginal Article. Breast Care 2016;11: DOI: /
Originl Article Brest Cre 2016;11:323 327 DOI: 10.1159/000452079 Published online: October 24, 2016 Neodjuvnt Chemotherpy with Docetxel, Crbopltin nd Weekly Trstuzumb Is Active in HER2-Positive Erly Brest
More informationRisk of Colorectal Cancer by Subsite in a Swedish Prostate Cancer Cohort
Specil Report Risk of Colorectl Cncer by Subsite in Swedish Prostte Cncer Cohort Yunxi Lu, MD, PhD, Rickrd Ljung, MD, PhD, Ann Mrtling, MD, PhD, nd Mts Lindbld, MD, PhD Bckground: The reltionship between
More informationEffects of TRPM8 on the proliferation and angiogenesis of prostate cancer PC-3 cells in vivo
ONCOLOGY LETTERS 2: 1213-1217, 2011 Effects of TRPM8 on the prolifertion nd ngiogenesis of prostte cncer PC-3 cells in vivo GUANGBIN ZHU, XINGHUAN WANG, ZHONGHUA YANG, HONG CAO, ZHE MENG, YONGZHI WANG
More informationProphylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications
Gstric Cncer (2018) 21:703 709 https://doi.org/10.1007/s10120-017-0781-y ORIGINAL ARTICLE Prophylctic effect of neodjuvnt chemotherpy in gstric cncer ptients with postopertive complictions Kojiro Eto 1
More informationBMI and Mortality: Results From a National Longitudinal Study of Canadian Adults
nture publishing group BMI nd Mortlity: Results From Ntionl Longitudinl Study of Cndin Adults Hether M. Orpn 1, Jen-Mrie Berthelot 2,3, Mrk S. Kpln 4, Dvid H. Feeny 5,6, Bentson McFrlnd 7 nd Nncy A. Ross
More informationIMpower133: Primary PFS, OS, and safety in a Ph1/3 study of 1L atezolizumab + carboplatin + etoposide in extensive-stage SCLC
IMpower133: Primry PFS, OS, nd sfety in Ph1/3 study of 1L tezolizumb + crbopltin + etoposide in extensive-stge SCLC S. V. Liu, 1 A. S. Mnsfield, 2 A. Szczesn, 3 L. Hvel, 4 M. Krzkowski, 5 M. J. Hochmir,
More informationOsteosarcoma in patients below 25 years of age: An observational study of incidence, metastasis, treatment and outcomes
ONCOLOGY LETTERS Osteosrcom in ptients below 25 yers of ge: An observtionl study of incidence, metstsis, tretment nd outcomes ZHIGANG NIE nd HAO PENG Deprtment of Orthopedics, Renmin Hospitl of Wuhn University,
More informationAnalysis of Risk Factors for the Development of Incisional and Parastomal Hernias in Patients after Colorectal Surgery
Originl Article Journl of the Koren Society of J Koren Soc Coloproctol 2012;28(6):299-303 http://dx.doi.org/10.3393/jksc.2012.28.6.299 pissn 2093-7822 eissn 2093-7830 Anlysis of Risk Fctors for the Development
More informationFactors Affecting Concordance between Radiological and Histological Findings in Invasive Lobular Carcinoma Experience from a National Cancer Centre
Originl Article DOI: 10.1159/000455066 Published online: Februry 7, 2017 Fctors Affecting Concordnce between Rdiologicl nd Histologicl Findings in Invsive Lobulr Crcinom Experience from Ntionl Cncer Centre
More informationCommunity. Profile Carter County. Public Health and Safety Division
Community Helth Profile 2015 Crter County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationEffect on Glycemic, Blood Pressure, and Lipid Control according to Education Types
Originl Article http://dx.doi.org/10.4093/dmj.2011.35.6.580 pissn 2233-6079 eissn 2233-6087 D I A B E T E S & M E T A B O L I S M J O U R N A L Effect on Glycemic, Blood Pressure, nd Lipid Control ccording
More informationR Martino 1, P Romero 1, M Subirá 1, M Bellido 1, A Altés 1, A Sureda 1, S Brunet 1, I Badell 2, J Cubells 2 and J Sierra 1
Bone Mrrow Trnsplnttion, (1999) 24, 283 287 1999 Stockton Press All rights reserved 0268 3369/99 $12.00 http://www.stockton-press.co.uk/bmt Comprison of the clssic Glucksberg criteri nd the IBMTR Severity
More informationSynovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers
Anlyticl Cellulr Pthology 16 (1998) 45 62 45 IOS Press Synovil srcom. Evlution of prognosis with emphsis on the study of DNA ploidy nd prolifertion (PCNA nd Ki-67) mrkers José M. Lopes,, Einr Hnnisdl b,
More informationAnalysis of detection results of thyroid function-related indexes in pregnant women and establishment of the reference interval
EXPERIMENTAL AND THERAPEUTIC MEDICINE Anlysis of detection results of thyroid function-relted indexes in pregnnt women nd estblishment of the reference intervl QI ZHOU 1*, YANLI ZHANG 1*, JIANHUA ZHOU
More informationCorrelation between CT features and liver function and p53 expression in hepatitis, cirrhosis and hepatocellular carcinoma
ONCOLOGY LETTERS Correltion between CT fetures nd liver function nd p53 expression in heptitis, cirrhosis nd heptocellulr crcinom YAHUI HU, JING WU, SHA LI nd XIAOXIAO ZHAO Deprtment of Nucler Medicine,
More informationFeeding state and age dependent changes in melaninconcentrating hormone expression in the hypothalamus of broiler chickens
Supplementry Mterils Epub: No 2017_23 Vol. 65, 2018 https://doi.org/10.183/bp.2017_23 Regulr pper Feeding stte nd ge dependent chnges in melninconcentrting hormone expression in the hypothlmus of broiler
More informationIntroduction. These patients benefit less from conventional chemotherapy than patients identified as MMR proficient or microsatellite stable 3-5
Nivolumb + Ipilimumb Combintion in Ptients With DNA Mismtch Repir-Deficient/Microstellite Instbility-High Metsttic Colorectl Cncer: First Report of the Full Cohort From CheckMte-142 Abstrct 553 André T,
More information27 June Bmnly L. WALTER ET AL.: RESPONSE OF CERVICAL CANCERS TO IRRADIATION
27 June 1964 Bmnly MEDICAL JOURNAL L. WALTER ET AL.: RESPONSE OF CERVICAL CANCERS TO IRRADIATION x 1,638.) FIG. 2.-Foci of sme tumour s in Fig. 1 contining vible tumour cells with scnty cytoplsm, reltively
More informationEvaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
1332 Evlution of the detection of 14 high-risk humn ppillomviruses with HPV 16 nd HPV 18 genotyping for cervicl cncer screening MEI-LU BIAN, JIAO-YING CHENG, LI MA, XIAO CONG, JUN LIU, YING CHEN nd XI
More informationMetabolic Syndrome and Health-related Quality of Life in Obese Individuals Seeking Weight Reduction
Metbolic Syndrome nd Helth-relted Qulity of Life in Obese Individuls Seeking Weight Reduction Adm Gilden Tsi 1, Thoms A. Wdden 1, Dvid B. Srwer 1, Robert I. Berkowitz 1, Leslie G. Womble 1, Louise A. Hesson
More informationSerum nesfatin-1 levels are decreased in pregnant women newly diagnosed with gestational diabetes
originl rticle Serum nesftin-1 levels re decresed in pregnnt women newly dignosed with gesttionl dibetes Esr Nur Ademoglu 1, Suheyl Gorr 2, Muge Keskin 3, Ayse Crlioglu 4, Rifki Ucler 5, Husmettin Erdmr
More informationSUPPLEMENTARY INFORMATION
SUPPEMENTARY INFORMATION DOI: 1.138/ncb956 Norml CIS Invsive crcinom 4 months months b Bldder #1 Bldder # Bldder #3 6 months (Invsive crcinom) Supplementry Figure 1 Mouse model of bldder cncer. () Schemtic
More informationPrognostic significance of microrna 200c in various types of cancer: An updated meta analysis of 34 studies
MOLECULAR AND CLINICAL ONCOLOGY 4: 933-941, 2016 Prognostic significnce of microrna 200c in vrious types of cncer: An updted met nlysis of 34 studies JIA YI ZHANG 1*, YA MIN WANG 1*, LE BIN SONG 2*, CHEN
More informationThe potential future of targeted radionuclide therapy: implications for occupational exposure? P. Covens
The potentil future of trgeted rdionuclide therpy: implictions for occuptionl exposure? Introduction: Trgeted Rdionuclide Therpy (TRT) Systemic tretment Molecule lbelled with rdionuclide delivers toxic
More informationRisk factors for HodgkinÕs disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents
DOI: 10.1054/ bjoc.1999.1049, vilble online t http://www.idelibrry.com on Risk fctors for HodgkinÕs disese by Epstein-Brr virus (EBV) sttus: prior infection by EBV nd other gents FE Alexnder 1, RF Jrrett
More informationMicroRNA 17 5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling
DOI 1.1186/s479-15-35-2 RESEARCH Open Access MicroRNA 17 5p induces drug resistnce nd invsion of ovrin crcinom cells y trgeting PTEN signling Ying Fng 1,2, Chngyn Xu 3 nd Yn Fu 1* Astrct Bckground: The
More informationBiliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan
J Heptoiliry Pncret Surg (2009) 16:1 7 DOI 10.1007/s00534-008-0015-0 TOPICS Biliry trct cncer sttistics registry in Jpn Biliry trct cncer tretment: 5,584 results from the Biliry Trct Cncer Sttistics Registry
More informationImplications for Human Leukocyte Antigen Antibodies After Lung Transplantation. A 10-Year Experience in 441 Patients
CHEST Originl Reserch TRANSPLANTATION Implictions for Humn Leukocyte Antigen Antibodies After Lung Trnsplnttion A 10-Yer Experience in 441 Ptients Lurie D. Snyder, MD, MHS ; Ziwei Wng, BS ; Dong-Feng Chen,
More information